Substrates for peptidase S08.001: subtilisin Carlsberg
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| alpha-2-macroglobulin | P01023 | 24-1474 | peptide-Arg719+Leu-peptide | P | Gly | His | Ala | Arg | Leu | Val | His | Val | Mortensen et al., 1981 | |||
| alpha-2-macroglobulin | P01023 | 24-1474 | peptide-Leu720+Val-peptide | P | His | Ala | Arg | Leu | Val | His | Val | Glu | Mortensen et al., 1981 | |||
| Antitrypsin | P22922 | 17-392 | Peptide-Tyr361+Val-Peptide | P | NT | Ser | Lys | Val | Tyr | Val | Arg | Pro | Pro | Sasaki et al., 1990 | ||
| Citrate synthase, mitochondrial | O75390 | 28-466 | Peptide-Ala348+Val-Peptide | N | NT | Tyr | Gly | His | Ala | Val | Leu | Arg | Lys | Lill et al., 1984 | ||
| Citrate synthase, mitochondrial | O75390 | 28-466 | Peptide-Val349+Leu-Peptide | N | NT | Gly | His | Ala | Val | Leu | Arg | Lys | Thr | Lill et al., 1984 | ||
| Glucoamylase | P69328 | 25-640 | Peptide-Val494+Ala-Peptide | N | NT | Pro | Ser | Ile | Val | Ala | Thr | Gly | Gly | Stoffer et al., 1993 | ||
| Glucoamylase | P69328 | 25-640 | Peptide-Ser467+Ser-Peptide | N | NT | Thr | Ser | Ala | Ser | Ser | Val | Pro | Gly | Stoffer et al., 1993 | ||
| Gly-Leu-Ala-Thr-Gly-Asn-Val-Ser-Thr-Ala-Glu-Leu-Gln-Asp-Ala-Thr-Pro-Ala-NHPhNO2 | Gly-Leu-Ala-Thr-Gly-Asn-Val-Ser-Thr-Ala-Glu-Leu-Gln-Asp-Ala-Thr-Pro-Ala+NHPhNO2 | S | Ala | Thr | Pro | Ala | NAN | - | - | - | Hauske et al., 2009 | |||||
| hirudin HM2 precursor | P81492 | 21-84 | peptide-Gln69+Thr-peptide | N | Pro | Lys | Ser | Gln | Thr | Glu | Gly | Asp | Vindigni et al., 1994 | |||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu+Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Val | Glu | Ala | Leu | Tyr | Leu | Val | Cya | Toogood et al., 2004 | |||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln+His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Phe | Val | Asn | Gln | His | Leu | Cya | Gly | Toogood et al., 2004 | |||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser+His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Leu | Cya | Gly | Ser | His | Leu | Val | Glu | Kraus et al., 1976 | |||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu+Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Gly | Ser | His | Leu | Val | Glu | Ala | Leu | Kraus et al., 1976 | |||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr+Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Glu | Ala | Leu | Tyr | Leu | Val | Cya | Gly | Kraus et al., 1976 | |||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu+Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Ala | Leu | Tyr | Leu | Val | Cya | Gly | Glu | Kraus et al., 1976 | |||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr+Thr-Pro-Lys-Ala | N | Gly | Phe | Phe | Tyr | Thr | Pro | Lys | Ala | Kraus et al., 1976 | |||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn+Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | - | Phe | Val | Asn | Gln | His | Leu | Cya | Johansen et al., 1968 | |||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya+Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | MS | Tyr | Leu | Val | Cya | Gly | Glu | Arg | Gly | Kobayashi et al., 2007 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His+Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | MS | Val | Asn | Gln | His | Leu | Cya | Gly | Ser | Kobayashi et al., 2007 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu+Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | MS | His | Leu | Val | Glu | Ala | Leu | Tyr | Leu | Kobayashi et al., 2007 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg+Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | MS | Cya | Gly | Glu | Arg | Gly | Phe | Phe | Tyr | Kobayashi et al., 2007 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe+Phe-Tyr-Thr-Pro-Lys-Ala | N | MS | Glu | Arg | Gly | Phe | Phe | Tyr | Thr | Pro | Kobayashi et al., 2007 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys+Ala | N | MS | Tyr | Thr | Pro | Lys | Ala | - | - | - | Kobayashi et al., 2007 | ||
| Lys-Gly-Lys-Asn-Ser-Gly-Ser-Gly-Ala-Thr-Pro-Val-NHPhNO2 | Lys-Gly-Lys-Asn-Ser-Gly-Ser-Gly-Ala-Thr-Pro-Val-NHPhNO2 | S | Ala | Thr | Pro | Val | NAN | - | - | - | Hauske et al., 2009 | |||||
| MAP kinase-activated protein kinase 2 | P49137 | 41-364 | Peptide-Lys49+Ser-Peptide | N | MS | Phe | His | Val | Lys | Ser | Gly | Leu | Gln | Tao et al., 2008 | ||
| MAP kinase-activated protein kinase 2 | P49137 | 41-364 | Peptide-Leu220+Thr-Peptide | N | MS | His | Asn | Ser | Leu | Thr | Thr | Pro | Cys | Tao et al., 2008 | ||
| MAP kinase-activated protein kinase 2 | P49137 | 41-364 | Peptide-Tyr228+Tyr-Peptide | N | MS | Tyr | Thr | Pro | Tyr | Tyr | Val | Ala | Pro | Tao et al., 2008 | ||
| MAP kinase-activated protein kinase 2 | P49137 | 41-364 | Peptide-Leu269+Ala-Peptide | N | MS | Asn | His | Gly | Leu | Ala | Ile | Ser | Pro | Tao et al., 2008 | ||
| myoglobin | P68082 | 2-154 | peptide-Leu90+Ala-peptide | N | Leu | Lys | Pro | Leu | Ala | Gln | Ser | His | Fontana et al., 1997 | |||
| myoglobin | P68082 | 2-154 | peptide-Gln92+Ser-peptide | N | Pro | Leu | Ala | Gln | Ser | His | Ala | Thr | Fontana et al., 1997 | |||
| myoglobin | P68082 | 2-154 | peptide-His94+Ala-peptide | N | Ala | Gln | Ser | His | Ala | Thr | Lys | His | Fontana et al., 1997 | |||
| ribonuclease, pancreatic | P61823 | 27-150 | peptide-Met105+Ser-peptide | N | Tyr | Ser | Thr | Met | Ser | Ile | Thr | Asp | Polverino de Laureto et al., 1997 | |||
| ribonuclease, pancreatic | P61823 | 27-150 | peptide-Tyr102+Ser-peptide | N | Tyr | Gln | Ser | Tyr | Ser | Thr | Met | Ser | Polverino de Laureto et al., 1997 | |||
| ribonuclease, pancreatic | P61823 | 27-150 | peptide-Ala46+Ser-peptide | N | Thr | Ser | Ala | Ala | Ser | Ser | Ser | Asn | Richards & Vithayathil, 1959 | |||
| ribonuclease, pancreatic | P61823 | 27-150 | peptide-Ser47+Ser-peptide | N | Ser | Ala | Ala | Ser | Ser | Ser | Asn | Tyr | Mendez et al., 2000 | |||
| ribonuclease, pancreatic | P61823 | 27-150 | peptide-Ser42+Thr-peptide | N | Met | Asp | Ser | Ser | Thr | Ser | Ala | Ala | Mendez et al., 2000 | |||
| ribonuclease, pancreatic | P61823 | 27-150 | peptide-Ser44+Ala-peptide | N | Ser | Ser | Thr | Ser | Ala | Ala | Ser | Ser | Mendez et al., 2000 | |||
| ribonuclease, pancreatic | P61823 | 27-150 | peptide-Ala45+Ala-peptide | N | Ser | Thr | Ser | Ala | Ala | Ser | Ser | Ser | Mendez et al., 2000 | |||
| Ser-Gly-Arg-Val-Val-Pro-Gly-Tyr-Gly-His-Ala-NHPhNO2 | Ser-Gly-Arg-Val-Val-Pro-Gly-Tyr-Gly-His-Ala+NHPhNO2 | S | Tyr | Gly | His | Ala | NAN | - | - | - | Hauske et al., 2009 | |||||
| serpin {ECO:0000313|EMBL:AEW22118.1} | G8UQY8 | 1-432 | peptide-Glu389+Met-peptide | P | NT | Thr | Ala | Val | Glu | Met | Val | Lys | Thr | Ksiazek et al., 2014 | ||
| Suc-Ala-Ala-Ala-NHPhNO2 | Suc-Ala-Ala-Ala-NHPhNO2 | S | Suc | Ala | Ala | Ala | NAN | - | - | - | ||||||
| Suc-Ala-Ala-Pro-Phe-NHPhNO2 | Suc-Ala-Ala-Pro-Phe+NHPhNO2 | S | Ala | Ala | Pro | Phe | NAN | - | - | - | Graycar et al., 2004 | |||||
| Z-Gly-Gly-Leu-NHPhNO2 | Z-Gly-Gly-Leu+NHPhNO2 | S | Z | Gly | Gly | Leu | NAN | - | - | - | Butler, 2004 |
